Vical other research news

The San Diego company received RAC clearance for two protocols with its Allovectin-7 gene therapy in renal cell carcinoma.

The gene, encoding an antigen that signals that a tissue is foreign, will be packaged in the company's cytofectin cationic lipid and injected directly into tumors. ...